Financials
Financial year 2025
Pharm'up development from Tournai, company number BE0881338337, closed financial year 2025 with a result of € 107,220 after tax. For that financial year Pharm'up development recorded a gross margin of € 157,338 and equity of € 153,486. Compared with financial year 2024, the result moved from € 100,381 to € 107,220. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 1, 2026.
€ 153,486
▲ 21% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 107,220
▲ 7% vs 2024
Profit after tax over the fiscal year.
€ 162,943
▲ 165% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 81,000 paid out
76 % of the profit went to the shareholders, the rest stayed in the company.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 3,297
▲ € 2,898 vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 33,930
▲ 147% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 165,648 | € 130,327 | € 133,213 | € 157,338 | ▲ 18% |
| Profit after taxes | € 121,855 | € 96,156 | € 100,381 | € 107,220 | ▲ 7% |
| Equity | € 154,729 | € 104,885 | € 127,266 | € 153,486 | ▲ 21% |
| Total debts | € 138,163 | € 186,027 | € 135,533 | € 133,205 | ▼ 2% |
| Cash | € 174,240 | € 174,892 | € 61,398 | € 162,943 | ▲ 165% |
| Retained profit | € 144,729 | € 94,885 | € 117,266 | € 143,486 | ▲ 22% |
| Dividend | € 110,000 | € 146,000 | € 78,000 | € 81,000 | ▲ 4% |
| Balance sheet total | € 292,892 | € 290,913 | € 262,799 | € 286,691 | ▲ 9% |
Key figures of Pharm'up development, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Pharm'up development?
What happened at Pharm'up development in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 107,220 (▲ 7% vs 2024). Source: NBB ↗
- New establishment in Tournai. KBO
- JEAN-FRANCOIS COPPE became a director. NBB
- MARC LEFEBURE became a director. NBB
- SEBASTIEN GOENEN became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 121,855 profit in 2022 to € 107,220 profit in 2025.
Paid € 160,243 in corporate taxes since 2022.
Best year ever: 2022, with € 121,855 profit.
Paid out € 415,000 in dividends to the owners in total.
A new publication or filing at Pharm'up development? We notify you, reason included.
Follow Pharm'up developmentDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Pharm'up development are JEAN-FRANCOIS COPPE, MARC LEFEBURE and SEBASTIEN GOENEN. JEAN-FRANCOIS COPPE is also behind Pharmacie de Gistoux. MARC LEFEBURE is also behind ML INVEST.
Directors
According to the 2025 annual accounts
since 2006
since 2006
SEBASTIEN GOENEN
Director
since 2006
Establishments
Establishment units
Physical locations of this company
Rue du Viaduc(TOU) 28
7500 Tournai
Boulevard Eisenhower(TOU) 25
7500 Tournai
Active since 12 June 2006
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
OVH Mail
Hosting
OVH, FR
Domain
Domain
pharmup.net
Registered
2015-05-29
Registrar
OVH, SAS
Expires
2028-05-29
Website info
Features
Security
Details
- Company number
- 0881.338.337
- VAT number
- BE 0881.338.337
- Registered office
- Rue du Viaduc(TOU) 28, 7500 Tournai
- Names & denominations
- Pharm'up development
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 11 April 2006
- Peppol
- Active · Active since 18 Dec 2025
- Contact
- pharmup.net
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Handelsbemiddeling in meubels, huishoudelijke artikelen en ijzerwaren
Handelsbemiddeling in de groothandel in meubelen, huishoudelijke artikelen en ijzerwaren
Overige zakelijke dienstverlening, neg